Literature DB >> 31606273

Distinct Binding Preferences between Ras and Raf Family Members and the Impact on Oncogenic Ras Signaling.

Elizabeth M Terrell1, David E Durrant1, Daniel A Ritt1, Nancy E Sealover2, Erin Sheffels2, Russell Spencer-Smith1, Dominic Esposito3, Yong Zhou4, John F Hancock4, Robert L Kortum2, Deborah K Morrison5.   

Abstract

The Ras GTPases are frequently mutated in human cancer, and, although the Raf kinases are essential effectors of Ras signaling, the tumorigenic properties of specific Ras-Raf complexes are not well characterized. Here, we examine the ability of individual Ras and Raf proteins to interact in live cells using bioluminescence resonance energy transfer (BRET) technology. We find that C-Raf binds all mutant Ras proteins with high affinity, whereas B-Raf exhibits a striking preference for mutant K-Ras. This selectivity is mediated by the acidic, N-terminal segment of B-Raf and requires the K-Ras polybasic region for high-affinity binding. In addition, we find that C-Raf is critical for mutant H-Ras-driven signaling and that events stabilizing B-Raf/C-Raf dimerization, such as Raf inhibitor treatment or certain B-Raf mutations, can allow mutant H-Ras to engage B-Raf with increased affinity to promote tumorigenesis, thus revealing a previously unappreciated role for C-Raf in potentiating B-Raf function.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31606273      PMCID: PMC7001861          DOI: 10.1016/j.molcel.2019.09.004

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  36 in total

1.  Formation of the Ras dimer is essential for Raf-1 activation.

Authors:  K Inouye; S Mizutani; H Koide; Y Kaziro
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

2.  Regulation of Raf-1 by direct feedback phosphorylation.

Authors:  Michele K Dougherty; Jürgen Müller; Daniel A Ritt; Ming Zhou; Xiao Zhen Zhou; Terry D Copeland; Thomas P Conrads; Timothy D Veenstra; Kun Ping Lu; Deborah K Morrison
Journal:  Mol Cell       Date:  2005-01-21       Impact factor: 17.970

3.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

Authors:  Yifang Hu; Gordon K Smyth
Journal:  J Immunol Methods       Date:  2009-06-28       Impact factor: 2.303

4.  Ras history: The saga continues.

Authors:  Adrienne D Cox; Channing J Der
Journal:  Small GTPases       Date:  2010-07

5.  A single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function.

Authors:  J R Fabian; A B Vojtek; J A Cooper; D K Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

Review 6.  Hyperactive Ras in developmental disorders and cancer.

Authors:  Suzanne Schubbert; Kevin Shannon; Gideon Bollag
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

Review 7.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

8.  KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.

Authors:  Chiara Ambrogio; Jens Köhler; Zhi-Wei Zhou; Haiyun Wang; Raymond Paranal; Jiaqi Li; Marzia Capelletti; Cristina Caffarra; Shuai Li; Qi Lv; Sudershan Gondi; John C Hunter; Jia Lu; Roberto Chiarle; David Santamaría; Kenneth D Westover; Pasi A Jänne
Journal:  Cell       Date:  2018-01-11       Impact factor: 41.582

9.  Improved vectors and genome-wide libraries for CRISPR screening.

Authors:  Neville E Sanjana; Ophir Shalem; Feng Zhang
Journal:  Nat Methods       Date:  2014-08       Impact factor: 28.547

10.  B- and C-RAF display essential differences in their binding to Ras: the isotype-specific N terminus of B-RAF facilitates Ras binding.

Authors:  Andreas Fischer; Mirko Hekman; Jürgen Kuhlmann; Ignacio Rubio; Stefan Wiese; Ulf R Rapp
Journal:  J Biol Chem       Date:  2007-07-16       Impact factor: 5.157

View more
  30 in total

1.  Validation of Isoform- and Mutation-Specific RAS Antibodies.

Authors:  Andrew M Waters; Channing J Der
Journal:  Methods Mol Biol       Date:  2021

2.  Anionic Lipids Impact RAS-Binding Site Accessibility and Membrane Binding Affinity of CRAF RBD-CRD.

Authors:  Timothy Travers; Cesar A López; Constance Agamasu; Jeevapani J Hettige; Simon Messing; Angel E García; Andrew G Stephen; S Gnanakaran
Journal:  Biophys J       Date:  2020-06-27       Impact factor: 4.033

3.  The KRAS and other prenylated polybasic domain membrane anchors recognize phosphatidylserine acyl chain structure.

Authors:  Yong Zhou; Priyanka S Prakash; Hong Liang; Alemayehu A Gorfe; John F Hancock
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

4.  Regulation of GTPase function by autophosphorylation.

Authors:  Christian W Johnson; Hyuk-Soo Seo; Elizabeth M Terrell; Moon-Hee Yang; Fenneke KleinJan; Teklab Gebregiworgis; Genevieve M C Gasmi-Seabrook; Ezekiel A Geffken; Jimit Lakhani; Kijun Song; Puspalata Bashyal; Olesja Popow; Joao A Paulo; Andrea Liu; Carla Mattos; Christopher B Marshall; Mitsuhiko Ikura; Deborah K Morrison; Sirano Dhe-Paganon; Kevin M Haigis
Journal:  Mol Cell       Date:  2022-02-23       Impact factor: 17.970

Review 5.  RAF kinase dimerization: implications for drug discovery and clinical outcomes.

Authors:  Tilman Brummer; Campbell McInnes
Journal:  Oncogene       Date:  2020-04-08       Impact factor: 9.867

6.  Swinhopeptolides A and B: Cyclic Depsipeptides from the Sponge Theonella swinhoei That Inhibit Ras/Raf Interaction.

Authors:  Chang-Kwon Kim; Dongdong Wang; Heidi R Bokesch; Richard W Fuller; Emily Smith; Curtis J Henrich; David E Durrant; Deborah K Morrison; Carole A Bewley; Kirk R Gustafson
Journal:  J Nat Prod       Date:  2020-03-19       Impact factor: 4.050

Review 7.  The Frequency of Ras Mutations in Cancer.

Authors:  Ian A Prior; Fiona E Hood; James L Hartley
Journal:  Cancer Res       Date:  2020-03-24       Impact factor: 12.701

8.  RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity.

Authors:  Pau Castel; Srisathiyanarayanan Dharmaiah; Matthew J Sale; Simon Messing; Gabrielle Rizzuto; Antonio Cuevas-Navarro; Alice Cheng; Michael J Trnka; Anatoly Urisman; Dominic Esposito; Dhirendra K Simanshu; Frank McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-17       Impact factor: 11.205

Review 9.  The Role of Wild-Type RAS in Oncogenic RAS Transformation.

Authors:  Erin Sheffels; Robert L Kortum
Journal:  Genes (Basel)       Date:  2021-04-28       Impact factor: 4.096

10.  A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation.

Authors:  Dhirendra K Simanshu; Deborah K Morrison
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.